¶¶Òõ´«Ã½ÔÚÏß

Russia's Rosatom has signed a fresh memorandum of cooperation with Kyrgyzstan, on non-energy application of nuclear technologies in healthcare, and updated the country on "progress of the development of a project for the construction" of a small modular reactor.

The first concrete has been poured for the Kijang Research Reactor at the Radiology Science Industrial Complex in Gijang-gun, Busan, the Korea Atomic ¶¶Òõ´«Ã½ÔÚÏß Research Institute announced.

The process of assembling the research reactor was reproduced at the manufacturing site in Russia ahead of it being shipped to Bolivia.

Brookhaven National Laboratory has announced the shipment of the first actinium-225 to be produced in a newly refurbished hot cell laboratory at the US Department of ¶¶Òõ´«Ã½ÔÚÏß's lab. The new facilities will streamline production and shipment of the rare radioisotope for the development of new cancer treatments.

Some 75-100 times more doses of next generation alpha targeted therapy treatments will be available annually worldwide, compared with today, through a project to produce isotopes from legacy nuclear material at the US Department of ¶¶Òõ´«Ã½ÔÚÏß's Oak Ridge National Laboratory, the project partners say.

The University of Missouri has launched an initiative to build a new, larger research reactor, NextGen MURR. The university's existing MU Research Reactor - in operation for more than half a century - is the highest-powered university research reactor in the USA and is currently the country's only producer of certain medical radioisotopes.

All major global molybdenum-99 production facilities are now using low-enriched uranium targets instead of proliferation-sensitive highly-enriched uranium following the completion of work to convert Belgium's National Institute of Radioelements medical isotope production facility.

The production of cobalt-60 is critical to healthcare and, with demand soaring, the challenge is to expand supply, writes Martin Comben from the International Irradiation Association.

President Luis Arce Catacora has delivered the first fluorodeoxyglucose radiopharmaceuticals produced in Bolivia's new Cyclotron Preclinical Radiopharmacy Complex to patients of the Nuclear Medicine and Radiotherapy Centres of El Alto and Santa Cruz.

A construction licence has been granted by the Authority for Nuclear Safety and Radiation Protection for the Pallas research reactor in Petten, the Netherlands. The new reactor will replace the existing High Flux Reactor.

A ground-breaking ceremony has been held in Mol in north-east Belgium to mark the start of construction of a facility to recycle radioactive residues from the production of medical radioisotopes. The RECUMO facility - which will recover uranium - is scheduled to begin operating in 2026.

Ontario Power Generation's nuclear power plant is set to produce molybdenum-99 after Laurentis ¶¶Òõ´«Ã½ÔÚÏß Partners and BWXT Medical Ltd completed the installation and initial commissioning of an innovative isotope system.